SCPA-EN-00071 Report

Item #: SCPA-EN-00071

Object Class: Keter

Special Containment Procedures:
SCPA-EN-00071 must be contained in a minimum of 2 sealed chambers, separated by an airlock. The first chamber must have a negative air pressure to prevent the spread of the virus, and must be equipped with UV-C irradiation and HEPA filters. The second chamber must only be opened for research purposes, and researchers must wear full-body containment suits before entering. A sample of SCPA-EN-00071 must be stored in the Foundation's Bio-Safety Level 4 laboratory. Any activity involving SCPA-EN-00071 must be approved and supervised by Level 4 personnel.

Description:
SCPA-EN-00071 is a virus that targets human beings, primarily through physical contact. SCPA-EN-00071 has a latency period of 2-4 days, which is not detectable through standard tests. SCPA-EN-00071 is known for its ability to mimic and replicate the genetic pattern of its host. Once SCPA-EN-00071 infests a host, it will begin to replicate their genetic material, effectively erasing their individual identity. SCPA-EN-00071 will also simulate the authentic responses of the host's body, immune system, and behaviors.

The symptoms of SCPA-EN-00071 are a mild fever, followed by rapid memory and cognitive decline leading to complete loss of identity, which can be lethal. SCPA-EN-00071 can be spread through any contact with the infected subject, including surfaces, fluids, respiration, and managed vectors. It is nearly impossible to detect SCPA-EN-00071 contagion, making it a dangerous threat to humanity.

Additional Information:
SCPA-EN-00071 was first found and contained in a remote village in northern China, where the outbreak caused rapid memory loss leading to death in approximately 60% of the population. The virus research facility that served as the original containment site was abandoned under mysterious circumstances, and the virus was presumed to have destroyed the site. There have been multiple attempted breaches since, leading to the confirmed presence of SCPA-EN-00071 at sites around the world.

References:

• Incident report SCPA-E-0382
• Experiment log SCPA-E-0456
• Biological threat assessment SCPA-BT-0003

Classification level:
Top Secret

Notice:
Any personnel working with SCPA-EN-00071 must undergo an extensive medical examination before and after contact, and reviewed by Level 4 personnel both times. All personnel must be combat-oriented, with proficiency in virus containment and countermeasures. All SCPA-EN-00071 incidents must be reported immediately to Level 4 Command.

Record #:
Incident Report SCPA-IR-000003

Reporter:
Dr. Akira Tanaka, Senior Researcher

Approver:
Director Jonathan Harland, Level 4 Command